Victory Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $504K | Buy |
+31,507
| New | +$504K | ﹤0.01% | 2058 |
|
|
2025
Q1 | – | Sell |
-45,100
| Closed | -$1.12M | – | 2501 |
|
|
2024
Q4 | $1.12M | Sell |
45,100
-290,260
| -87% | -$7.19M | ﹤0.01% | 1757 |
|
|
2024
Q3 | $9.56M | Buy |
335,360
+22,990
| +7% | +$655K | 0.01% | 1120 |
|
|
2024
Q2 | $8.25M | Sell |
312,370
-6,631
| -2% | -$175K | 0.01% | 1132 |
|
|
2024
Q1 | $10.3M | Sell |
319,001
-6,533
| -2% | -$211K | 0.01% | 1056 |
|
|
2023
Q4 | $13.7M | Sell |
325,534
-47,237
| -13% | -$1.99M | 0.01% | 921 |
|
|
2023
Q3 | $14.3M | Sell |
372,771
-205,364
| -36% | -$7.88M | 0.02% | 882 |
|
|
2023
Q2 | $11M | Sell |
578,135
-87,650
| -13% | -$1.66M | 0.01% | 1007 |
|
|
2023
Q1 | $10.3M | Buy |
+665,785
| New | +$10.3M | 0.01% | 1017 |
|
|
2021
Q1 | – | Sell |
-6,888
| Closed | -$318K | – | 2761 |
|
|
2020
Q4 | $318K | Buy |
6,888
+1,073
| +18% | +$49.5K | ﹤0.01% | 2266 |
|
|
2020
Q3 | $205K | Buy |
+5,815
| New | +$205K | ﹤0.01% | 2281 |
|